PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NASA: Fire vs. ice: The science of ISON at perihelion

2013-12-11
(Press-News.org) Contact information: Susan Hendrix
Susan.m.hendrix@nasa.gov
301-286-7745
NASA/Goddard Space Flight Center
NASA: Fire vs. ice: The science of ISON at perihelion

After a year of observations, scientists waited with bated breath on Nov. 28, 2013, as Comet ISON made its closest approach to the sun, known as perihelion. Would the comet disintegrate in the fierce heat and gravity of the sun? Or survive intact to appear as a bright comet in the pre-dawn sky?

Some remnant of ISON did indeed make it around the sun, but it quickly dimmed and fizzled as seen with NASA's solar observatories. This does not mean scientists were disappointed, however. A worldwide collaboration ensured that observatories around the globe and in space, as well as keen amateur astronomers, gathered one of the largest sets of comet observations of all time, which will provide fodder for study for years to come.

On Dec. 10, 2013, researchers presented science results from the comet's last days at the 2013 Fall American Geophysical Union meeting in San Francisco, Calif. They described how this unique comet lost mass in advance of reaching perihelion and most likely broke up during its closest approach, as well, as summarized what this means for determining what the comet was made of.

"The comet's story begins with the very formation of the solar system," said Karl Battams, an astrophysicist at the Naval Research Lab in Washington, D.C. "The dirty snowball that we came to call Comet ISON was created at the same time as the planets."

ISON circled the solar system in the Oort cloud, more than 4.5 trillion miles away from the sun. At some point a few million years ago, something occurred – perhaps the passage of a nearby star – to knock ISON out of its orbit and send it hurtling along a path for its first trip into the inner solar system.

The comet was first spotted 585 million miles away in September 2012 by two Russian astronomers: Vitali Nevski and Artyom Novichonok. The comet was named after the project that discovered it, the International Scientific Optical Network, or ISON, and given an official designation of C/2012 S1 (ISON). When comet scientists mapped out Comet ISON's orbit they learned that the comet would swing within 1.1 million miles of the sun's surface, making it what's known as a sungrazing comet, providing opportunities to study this pristine bit of the early solar system as it lost material while approaching the higher temperatures of the sun. With this knowledge, an international campaign to observe the comet was born. The number of space-based, ground-based, and amateur observations was unprecedented, including 12 NASA space-based assets observing Comet ISON over the past year.

Near the beginning of October, 2013, two months before perihelion, NASA's Mars Reconnaissance Observer, or MRO, turned its HiRISE instrument to view the comet during its closest approach to Mars in October 2013.

"The size of ISON's nucleus could be a little over half a mile across --- at the most. Very likely it could have been as small as several hundred yards," said Alfred McEwen, the principal investigator for the HiRISE instrument at Arizona State University, in Tucson.

In other words, Comet ISON might have been the length of five or six football fields. This small size was near the borderline of how big ISON needed to be to survive its trip around the sun.

During that trip around the sun, Geraint Jones, a comet scientist at University College London's Mullard Space Science Laboratory in the UK studied the comet's dust tails to better understand what happened as it rounded the sun. By fitting models of the dust tail to the actual observations from NASA's Solar Terrestrial Observatory, or STEREO, and the joint European Space Agency/NASA Solar and Heliospheric Observatory, or SOHO, Jones showed that very little dust was produced after perihelion, which may suggest that the comet's nucleus had already broken up by that time.

While the comet was visible in STEREO and SOHO images going into perihelion, it was not visible in the data from NASA's Solar Dynamics Observatory, or SDO, or from ground based solar observatories during its closest approach to the sun. Dean Pesnell, project scientist for SDO at NASA's Goddard Space Flight Center in Greenbelt, Md., explained why Comet ISON wasn't visible in SDO and what could be learned from that: SDO is tuned to see wavelengths of light that would indicate the presence of oxygen, which is very common in comets.

"The fact that ISON did not show oxygen despite how close it came to the sun provides information about how high was the evaporation temperature of ISON's material," said Pesnell. "This limits what it could have been made of."

When Comet ISON was first spotted in September 2012, it was relatively bright for a comet at such a great distance from the sun. Consequently, many people had high hopes it would provide a beautiful light show visible in the night sky throughout December 2013. That potential ended when Comet ISON disrupted during perihelion. However, the legacy of the comet will go on for years as scientists analyze the tremendous data set collected during ISON's journey.



INFORMATION:



NASA's Comet ISON website: http://www.nasa.gov/cometison



ELSE PRESS RELEASES FROM THIS DATE:

Researchers to present event-free and overall survival results from NeoALTTO trial

2013-12-11
Researchers to present event-free and overall survival results from NeoALTTO trial SAN ANTONIO — Results from the initial analysis of event-free and overall survival for patients enrolled in the randomized, phase III Neoadjuvant Lapatinib and/or ...

High levels of immune cells in tumors may ID breast cancer pts most likely benefit from trastuzumab

2013-12-11
High levels of immune cells in tumors may ID breast cancer pts most likely benefit from trastuzumab SAN ANTONIO — Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from ...

Study identifies highly effective treatment option for patients with HER2-positive breast cancer

2013-12-11
Study identifies highly effective treatment option for patients with HER2-positive breast cancer SAN ANTONIO — Combining the chemotherapy drugs docetaxel and carboplatin with the HER2-targeted therapy trastuzumab was identified to be an ideal ...

Combined therapy linked to lower chance of recurrence in women with small, HER2+ breast cancers

2013-12-11
Combined therapy linked to lower chance of recurrence in women with small, HER2+ breast cancers SAN ANTONIO— In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted ...

Staph can lurk deep within nose, Stanford study finds

2013-12-11
Staph can lurk deep within nose, Stanford study finds STANFORD, Calif. — Scientists at the Stanford University School of Medicine have revealed that formerly overlooked sites deep inside the nose may be reservoirs for Staphylococcus aureus, a major ...

Post-Sandy, Long Island barrier systems appear surprisingly sound

2013-12-11
Post-Sandy, Long Island barrier systems appear surprisingly sound Long-term concerns remain about effects of sea-level rise and churned up pollutants VIDEO: In ...

Herceptin plus taxol highly effective in lower-risk breast cancer patients

2013-12-11
Herceptin plus taxol highly effective in lower-risk breast cancer patients 98.7 percent are cancer free for at least 3 years MAYWOOD, Ill. – A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after ...

Hydrogen-powered invasion

2013-12-11
Hydrogen-powered invasion The intestine is bustling with billions of intestinal bacteria that aid digestion and keep it healthy. A vast array of microorganisms (microbiota) colonise the intestine so densely that pathogens do not usually stand a chance of multiplying. ...

Scientists discover chemical modification in human malaria parasite DNA

2013-12-11
Scientists discover chemical modification in human malaria parasite DNA Findings by UC Riverside researchers could help build a new drug to kill the deadly parasite that is becoming resistant to existing drugs RIVERSIDE, Calif. -- Say "malaria" and ...

Incarceration has no effect on nonresident fathers' parenting

2013-12-11
Incarceration has no effect on nonresident fathers' parenting WASHINGTON, DC, December 11, 2013 — A prison sentence may not always have negative consequences for children of the incarcerated, says University of California, Irvine sociologist Kristin ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] NASA: Fire vs. ice: The science of ISON at perihelion